Ignite Creation Date:
2024-05-06 @ 6:32 PM
Last Modification Date:
2025-12-17 @ 3:34 AM
Study NCT ID:
NCT05695391
Status:
None
Last Update Posted:
2025-07-09 00:00:00
First Post:
2022-12-21 00:00:00
Brief Title:
A Phase 3 Study of the Safety and Efficacy of Coagulation Factor VIIa (Recombinant) for the Prevention of Excessive Bleeding in Patients With Congenital Hemophilia A or B With Inhibitors to Factor VIII or IX Undergoing Elective Major Surgical Procedures SCOPE HIM
Sponsor:
Laboratoire français de Fractionnement et de Biotechnologies
Organization:
Laboratoire français de Fractionnement et de Biotechnologies
Organization Data
Organization:
Laboratoire français de Fractionnement et de Biotechnologies
Class:
INDUSTRY
Study ID:
F7TG2202
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Laboratoire français de Fractionnement et de Biotechnologies
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None